MultiplexDX obtained a €3.5m grant from EU
MultiplexDX (Pavol Čekan and Vladimír Wolf) obtained a €3.5m grant from the European Innovation Council that has allocated €278m to 75 European and global startups. MultiplexDX develops personalized molecular diagnostics for breast cancer. It will use the money for clinical validation to persuade oncologists to offer their diagnostics to their patients.
